SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 50.05 |
| Enterprise Value ($M) | 33.26 |
| Book Value ($M) | 17.50 |
| Book Value / Share | 0.28 |
| Price / Book | 2.86 |
| NCAV ($M) | 10.45 |
| NCAV / Share | 0.16 |
| Price / NCAV | 4.79 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.47 |
| Return on Assets (ROA) | -0.75 |
| Return on Equity (ROE) | -1.35 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.84 |
| Current Ratio | 1.84 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 25.14 |
| Assets | 32.19 |
| Liabilities | 14.69 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 9.29 |
| Operating Income | -41.59 |
| Net Income | -40.67 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -36.33 |
| Cash from Investing | 0.03 |
| Cash from Financing | 10.24 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Bleichroeder LP | 9.99 | 0.00 | |
| 13G/A | Slate Path Capital LP | 1.40 | -61.75 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 114,045 | 208,871 | 54.60 | |
| 48,109 | 197,977 | 24.30 | |
| 154,762 | 368,723 | 41.97 | |
| 35,814 | 99,129 | 36.13 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CSBR – Champions Oncology, Inc. | CSCI – COSCIENS Biopharma Inc. |
| CTXR – Citius Pharmaceuticals, Inc. | CVKD – Cadrenal Therapeutics, Inc. |
| CYCC – Cyclacel Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io